Inhibition of alternative pathway factor D by factor B ‐related synthetic hexapeptides
- 1 January 1982
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 12 (3) , 252-254
- https://doi.org/10.1002/eji.1830120317
Abstract
Hexapeptides mimicking the partial amino acid sequence of factor B surrounding the bond that is cleaved by factor D have been synthesized. These peptides have been assessed for their ability to inhibit factor D enzymatic activity and for their susceptibility to serine proteases. The synthetic peptides were cleaved by bovine trypsin and Cls but not by α‐thrombin and factor D. The peptides inhibited factor B cleavage and fluid‐phase or cell‐bound alternative pathway C3 convertase activation by factor D. Altogether, these results suggest that peptides analogous to factor B specifically inhibit factor D enzymatic activity. Thus, they constitute an interesting tool for study of alternative pathway activation and can be of use when attempting to manipulate this pathway, since factor D is an essential component for alternative pathway initiation and amplification.This publication has 16 references indexed in Scilit:
- Active site amino acid sequence of human factor D.Proceedings of the National Academy of Sciences, 1980
- Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and BbBiochemistry, 1980
- Partial amino acid sequence of human factor D:homology with serine proteases.Proceedings of the National Academy of Sciences, 1980
- Mechanism of action of factor D of the alternative complement pathway.The Journal of Experimental Medicine, 1978
- Human thrombin: Partial primary structureArchives of Biochemistry and Biophysics, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement PathwaysScandinavian Journal of Immunology, 1976
- Alternative Pathway for the Activation of Complement in Human Serum. Formation and Composition of the Complex with Cobra Venom Factor that Cleaves the Third Component of ComplementBiological Chemistry, 1974
- C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTIONThe Journal of Experimental Medicine, 1972
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965